Showing results (1641-1650 of 3,833) with videos related to

Sort By:
Pageof 384
The Japanese Journal of Antibiotics|January 1, 1990
Prophylactic and therapeutic effects of oral administration of amphotericin B in mycosis associated with hematologic diseases. Study Group of Mycosis in Hematologic DiseaseA Urabe, F Takaku, H Mizoguchi, et al.
The Japanese Journal of Antibiotics|January 1, 1990
Randomized trial of combination antibiotic therapy in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and InfectionY Takemoto, A Kanamaru, K Nagai, et al.
The Japanese Journal of Antibiotics|December 1, 1995
[Antimicrobial activities of cefepime against clinically isolated strains]Y Suzuki, M Koguchi, S Tanaka, et al.
The Japanese Journal of Antibiotics|May 1, 1996
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution]Y Kumamoto, T Hirose, A Yokoo, et al.
The Japanese Journal of Antibiotics|May 1, 1996
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). II. Background of patients]Y Kumamoto, T Hirose, A Yokoo, et al.
The Japanese Journal of Antibiotics|February 1, 1996
[Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)]H Ikemoto, K Watanabe, T Mori, et al.
The Japanese Journal of Antibiotics|February 1, 1996
[Antimicrobial activities of meropenem against clinically isolated strains]K Deguchi, M Koguchi, Y Suzuki, et al.
The Japanese Journal of Antibiotics|January 1, 1993
[Microbiological determination of netilmicin using a thin-layer chromatography scanner]Y Tsuda, H Wakamatsu, E Yoshizawa, et al.
The Japanese Journal of Antibiotics|January 1, 1993
[Clinical studies of ofloxacin 300 mg once a day administration in chronic respiratory tract infections]H Fukuhara, N Kusano, Y Irabu, et al.
The Japanese Journal of Antibiotics|January 1, 1993
[Effects of a combination therapy consisting of arbekacin and ampicillin of methicillin-resistant Staphylococcus aureus]K Deguchi, N Yokota, M Koguchi, et al.
Pageof 384